Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour

Authors

  • Anastasia Constantinidou Medical Oncology, Sarcoma Unit, The Royal Marsden Hospital, London, UK
  • Robin L. Jones Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Centre, Seattle, WA, USA
  • David Olmos Medical Oncology, Sarcoma Unit, The Royal Marsden Hospital, London, UK
  • Khin Thway Department of Histopathology, The Royal Marsden Hospital, London, UK
  • Cyril Fisher Department of Histopathology, The Royal Marsden Hospital, London, UK
  • Omar Al-Muderis Medical Oncology, Sarcoma Unit, The Royal Marsden Hospital, London, UK
  • Ian Judson Medical Oncology, Sarcoma Unit, The Royal Marsden Hospital, London, UK

DOI:

https://doi.org/10.3109/0284186X.2011.626450

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2012-04-01

How to Cite

Constantinidou, A., Jones, R. L., Olmos, D., Thway, K., Fisher, C., Al-Muderis, O., & Judson, I. (2012). Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour. Acta Oncologica, 51(4), 550–554. https://doi.org/10.3109/0284186X.2011.626450